Complete report $1,850. Individual company assessments $250. The companies analyzed in this report include BASF, Cambrex, Clariant, DowPharma, DSM, Evonik, Lanxess, Lonza, Novasep, and Rhodia. For each company, the report presents: • Major promotional strategies. • Distribution approaches. • Product service and support. Contains 20 pages
|